The VR Foundation's Scientific Advisory Board directs the clinical development portion of the Research model, offering potential commercial biopharma partners the highest-level of expertise in vitiligo pre/clinical trials.
Our goal is to shorten the time for clinical trials, in order for patients to receive promising treatments sooner, while making the drug development process more cost-effective and efficient for the pharmaceutical industry. Read more about our Centers Of Excellence in vitiligo.
VR Foundation has put forward a clear vision for the standardisation of clinical data and vitiligo medical records. Currently, it is easier to collect data on vitiligo patients for prospective clinical trials in advance than it is to access similar clinical data retrospectively. Read more »
The purpose of our Drug Screening program is to identify the existing drugs that are likely to be beneficial to vitiligo patients.
Initially, we focused on off-label use of approved drugs that already on the market and thus available to patients immediately. Results from this screening could provide the rationale needed to justify new clinical trials, and could quickly impact the treatment of vitiligo patients. »»»
Clinical trials are a crucial step in the development of new treatments for any disease. For vitiligo patients clinical trials can offer access to promising new treatments, often before they become available in the clinics. In addition to having the potential to benefit from the latest treatments, vitiligo patients who participate in clinical trials will help researchers learn about vitiligo and how to effectively treat this neglected skin disease.
There is a number of independently funded projects in Australia, Austria, Brazil, Canada, France, Netherlands, Spain, Taiwan, Thailand and other countries that are looking for participants »
Why clinical trials? New to clinical trials entirely? Have you tried but it did not work for you? Continue reading »
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
How can I treat vitiligo?
Choosing a treatment for vitiligo can be difficult, sometimes overwhelming. In general, first-line therapy should be safe, effective, minimally invasive, and cost effi...
I have vitiligo: will my children have vitiligo, too?
Although most cases of vitiligo are sporadic, familial clustering is not uncommon, and up to 20% of patients report on the affected relatives. In whites, the lifetime ...
Is it possible to stop the progression of vitiligo?
Vitiligo is progressive in 73% of cases and regressive in 1.3%. We usually explain to the patients that progression depends on the modality of the disease spreading: l...
What causes vitiligo?
It remains unclear what causes damage to melanocytes and their subsequent total inactivation and/or disappearance in vitiligo skin. There are several theories; the mos...